> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Cancer Trials Eligibility for HIV Patients
- URL: https://www.fdaweb.com/draft-guide-on-cancer-trials-eligibility-for-hiv-patients/
- Published: 2019-03-14T12:00:00.000Z
- Updated: 2026-09-15T01:12:43.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143610

*Federal Register* notice: FDA has made available a draft guidance entitled “Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections.” The document provides recommendations on including such patients because expanding cancer clinical trial eligibility to be more inclusive is justified in many cases, and may accelerate the development of effective therapies in cancer patients with these chronic infections. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-03-13/pdf/2019-04572.pdf?ref=fdaweb.com).